Evangelisches Krankenhaus Hamm

Hamm 59063

0 studies enrolling now · 4 studies all time

What they study most

Asthma, Carcinoma, Non-Small-Cell Lung, Chronic Lymphocytic Leukemia, Malignant Pleural Mesothelioma, Small Lymphocytic Lymphoma

Studies at this site

• A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication — Stopped early
• Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma — Completed
• A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia — Completed
• A Study of Tislelizumab (BGB-A317) Plus Chemoradiotherapy Followed by Tislelizumab Monotherapy in Newly Diagnosed, Stage III Subjects With Locally Advanced, Unresectable Non-small Cell Lung Cancer — Stopped early